Clinical outcomes of conversion surgery following neoadjuvant chemoimmunotherapy in potentially resectable stage IIIA/IIIB non-small cell lung

Abstract Neoadjuvant chemoimmunotherapy has been successfully used in patients with resectable non-small-cell lung cancer (NSCLC). However, its application to potentially resectable IIIA/IIIB NSCLC remains controversial. This retrospective study aims to evaluate the efficacy and safety of neoadjuvan...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Yana Qi, Yulan Sun, Yanran Hu, Hui Zhu, Hongbo Guo
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Subjects:
Non-small-cell lung cancer
Potentially resectable
Neoadjuvant chemoimmunotherapy
Conversion surgery
Online Access:https://doi.org/10.1038/s41598-025-99571-y

Internet

https://doi.org/10.1038/s41598-025-99571-y

Similar Items